Search Login Register
eletriptan
(Relpax)
Summary
Description:
5-HT(1B/1D) receptor agonist; structure in first source
Also Known As:
Relpax; 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide; Mack brand of eletriptan hydrobromide; Pfizer brand of eletriptan hydrobromide; UK 166,044 Show All >>
Networked: 111
relevant articles (39 outcomes,
43 trials/studies)
for this Drug
Key Diseases for which eletriptan is
Relevant
-
Migraine Disorders (Migraine)
:
33 outcomes 38 studies in 92 results
-
Headache (Headaches)
:
10 outcomes 9 studies in 41 results
-
Epilepsy (Aura)
:
2 outcomes 3 studies in 8 results
-
Pain (Aches)
:
1 outcome 5 studies in 15 results
-
Cluster Headache (Cluster Headaches)
:
1 outcome 1 study in 1 result
Show All >>
Drugs Related to eletriptan
-
Pain-Free
-
Sumatriptan (Imigran)
-
rizatriptan (Maxalt)
-
eletriptan (Relpax)
-
almotriptan (Axert)
-
Serotonin (5 Hydroxytryptamine)
-
naratriptan
-
zolmitriptan (Zomig)
-
frovatriptan (Allegro)
-
Tryptamines (Triptans)
Show All >>
Therapies Related to eletriptan
-
Aftercare (After-Treatment)
-
Stents
-
Nebulizers and Vaporizers (Inhaler)
-
Oral Administration
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.